Received Jun 15, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MNP | MENINGOCOCCAL CONJUGATE (PENMENVY) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 55ZX7 | — |
Inadvertent Administration of Only the Prefilled Syringe of the Liquid MenB Component of Penmenvy; Inadvertent Administration of Only the Prefilled Syringe of the Liquid MenB Component of Penmenvy; This non-serious case was reported by a nurse via call center representative and described the occurrence of inappropriate preparation of medication in a 16-year-old female patient who received Men ABCWY NVS (Penmenvy) suspension for injection in pre-filled syringe (batch number 55ZX7 with expiry date 20-NOV-2026) for prophylaxis. On 04-JUN-2026, the patient received Penmenvy. On 04-JUN-2026, an unknown time after receiving Penmenvy, the patient experienced inappropriate preparation of medication (Verbatim: Inadvertent Administration of Only the Prefilled Syringe of the Liquid MenB Component of Penmenvy) and inappropriate dose of vaccine administered (Verbatim: Inadvertent Administration of Only the Prefilled Syringe of the Liquid MenB Component of Penmenvy). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 11-JUN-2026 The reporter wanted to know if there is any other diluent they can use to reconstitute the powder. This case is linked with case US2026076465, reported by the same reporter.; Sender's Comments: US-GSK-US2026076465:same reporter